Cefotetan: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
m (Changed protection level for "Cefotetan" ([Edit=Allow only autoconfirmed users] (expires 15:02, 22 January 2014 (UTC)) [Move=Allow only autoconfirmed users] (expires 15:02, 22 January 2014 (UTC))))
No edit summary
Line 1: Line 1:
{{drugbox
__NOTOC__
| IUPAC_name        = (7''S'')-7-{[4-(1-amino-3-hydroxy-1,3-dioxopropan-2-ylidene)<br>1,3-dithietane-2-carbonyl]amino}-7-methoxy-<br>3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-<br>5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
| image            = Cefotetan.svg
| width            = 250
| CAS_number        = 69712-56-7
| ATC_prefix        = J01
| ATC_suffix        = DC05
| PubChem          = 50614
| DrugBank          =
| C = 17 | H = 17 | N = 7 | O = 8 | S = 4
| molecular_weight  = 575.623 g/mol
| bioavailability  =
| protein_bound    =
| metabolism        =
| elimination_half-life =
| excretion        =
| pregnancy_AU      =  <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US      =  <!-- A / B            / C / D / X -->
| pregnancy_category= 
| legal_AU          =  <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA          =  <!--            / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK          =  <!-- GSL        / P      / POM / CD / Class A, B, C -->
| legal_US          =  <!-- OTC                  / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status      =
| routes_of_administration =
}}
{{SI}}


{{Cefotetan}}


{{CMG}};{{AE}}{{AK}}
'''''For patient information, click <u>[[Cefotetan Disodium(patient information)|here]]'''''</u>
==Overview==
'''Cefotetan''' is an injectable [[antibiotic]] of the [[cephamycin]] type for prophylaxis and treatment of [[bacterial infection]]s. It is often grouped together with second-generation [[cephalosporin]]s and has a similar antibacterial spectrum, but with additional anti-anaerobe converage.
'''Cefotetan''' is an injectable [[antibiotic]] of the [[cephamycin]] type for prophylaxis and treatment of [[bacterial infection]]s. It is often grouped together with second-generation [[cephalosporin]]s and has a similar antibacterial spectrum, but with additional anti-anaerobe converage.


Cefotetan was developed by [[Yamanouchi]]. It is marketed outside Japan by [[AstraZeneca]] with the brand names '''Apatef''' and '''Cefotan'''.
Cefotetan was developed by [[Yamanouchi]]. It is marketed outside Japan by [[AstraZeneca]] with the brand names '''Apatef''' and '''Cefotan'''.


==External links==
*[http://www.cefotan.com/content/products/productDisplay.asp?id=32 Cefotan official web site] run by [[AstraZeneca]] US
*[http://www.rxlist.com/cgi/generic2/cefotet.htm Cefotetan] entry in RxList


{{CephalosporinAntiBiotics}}
==Category==
[[Cephalosporins]], second generation.


[[category:cephalosporin antibiotics]]


==US Brand Names==


[[th:เซโฟตีแทน]]
CEFOTETAN®
{{WikiDoc Help Menu}}
 
{{WS}}
==FDA Package Insert==
'''  [[Cefotetan description|Description]]'''
'''| [[Cefotetan clinical pharmacology|Clinical Pharmacology]]'''
'''| [[Cefotetan microbiology|Microbiology]]'''
'''| [[Cefotetan indications and usage|Indications and Usage]]'''
'''| [[Cefotetan contraindications|Contraindications]]'''
'''| [[Cefotetan warnings and precautions|Warnings and Precautions]]'''
'''| [[Cefotetan adverse reactions|Adverse Reactions]]'''
'''| [[Cefotetan overdosage|Overdosage]]'''
'''| [[Cefotetan clinical studies|Clinical Studies]]'''
'''| [[Cefotetan dosage and administration|Dosage and Administration]]'''
'''| [[Cefotetan Compatibility and Stability|Compatibility and Stability]]'''
'''| [[Cefotetan how supplied|How Supplied]]'''
'''| [[Cefotetan labels and packages|Labels and Packages]]'''
 
 
==References==
{{Reflist|2}}
http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/50588slr027_cefotan_lbl.pdf
[[Category:Antibiotics]]
[[Category:Wikinfect]]

Revision as of 07:23, 10 January 2014


Cefotetan
CEFOTETAN® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Dosage and Administration
Compatibility and Stability
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2] For patient information, click here

Overview

Cefotetan is an injectable antibiotic of the cephamycin type for prophylaxis and treatment of bacterial infections. It is often grouped together with second-generation cephalosporins and has a similar antibacterial spectrum, but with additional anti-anaerobe converage.

Cefotetan was developed by Yamanouchi. It is marketed outside Japan by AstraZeneca with the brand names Apatef and Cefotan.


Category

Cephalosporins, second generation.


US Brand Names

CEFOTETAN®

FDA Package Insert

Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Overdosage | Clinical Studies | Dosage and Administration | Compatibility and Stability | How Supplied | Labels and Packages


References

http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/50588slr027_cefotan_lbl.pdf

Retrieved from "https://www.wikidoc.org/index.php?title=Cefotetan&oldid=931673"